Gastrointestinal Endoscopy Market Report 2026

The gastrointestinal endoscopy market size has grown strongly in recent years. It will grow from $16.78 billion in 2025 to $17.92 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to hospital-based diagnostic expansion, widespread use of flexible endoscopes, growth in gi disorder prevalence, advancement in visualization systems, adoption of biopsy techniques.

The gastrointestinal endoscopy market size is expected to see strong growth in the next few years. It will grow to $23.72 billion in 2030 at a compound annual growth rate (CAGR) of 7.3%. The growth in the forecast period can be attributed to ai-enabled image analysis, demand for infection control solutions, growth in outpatient procedures, expansion of robotic endoscopy, technological innovation in imaging. Major trends in the forecast period include increasing adoption of minimally invasive diagnostic procedures, rising demand for high-definition endoscopic imaging, growth of capsule endoscopy usage, expansion of single-use endoscopes, integration of ai in endoscopic diagnostics.

The rising prevalence of gastrointestinal diseases is expected to drive the growth of the gastrointestinal endoscopy market in the coming years. Gastrointestinal diseases encompass a range of disorders affecting the gastrointestinal (GI) tract, including the organs responsible for digestion and food processing. Gastrointestinal endoscopy is a commonly used procedure for detecting abnormalities, obtaining tissue samples for biopsy, and performing therapeutic interventions in the diagnosis and treatment of gastrointestinal disorders. For example, in 2023, Cancer Research UK, a UK-based independent cancer research organization, projected that the incidence of pancreatic cancer in the UK would rise by 5% from 2023 to 2025. Additionally, in March 2023, a study published in the Journal of the Canadian Association of Gastroenterology, a Canada-based open-access peer-reviewed journal, estimated that the incidence of inflammatory bowel disease in Canada would increase from 825 per 100,000 in 2023 to 1,075 per 100,000 by 2035. Consequently, the increasing prevalence of gastrointestinal diseases is driving the gastrointestinal endoscopy market.

Key players in the gastrointestinal endoscopy market are launching innovative endoscopic devices that incorporate advanced imaging technologies to enhance diagnostic accuracy and improve patient outcomes. These imaging technologies include high-definition imaging, narrow-band imaging (NBI), and optical coherence tomography (OCT), which offer clearer and more detailed visualization of the gastrointestinal tract during endoscopic procedures. For instance, in October 2023, Olympus Corporation, a Japan-based manufacturing company, introduced the EVIS X1 Endoscopy System. The EVIS X1 system is a next-generation endoscopy tool designed to improve visualization of the gastrointestinal tract using advanced imaging technologies such as TXI, RDI, and NBI, thereby enhancing physicians’ ability to detect abnormalities during GI procedures.

In April 2023, Boston Scientific, a US-based biomedical engineering company, acquired Apollo Endosurgery for $615 million. This acquisition enables Boston Scientific to expand its offerings in endoluminal surgery procedures and endo-bariatric solutions. Apollo Endosurgery, a US-based manufacturer, specializes in endoscopy devices and solutions for gastrointestinal endoscopy.

Major companies operating in the gastrointestinal endoscopy market are Medtronic plc, Johnson & Johnson MedTech, FUJIFILM Holdings Corporation, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc., HOYA Corporation, Steris plc, Karl Storz SE & Co. KG, Ambu A/S, Richard Wolf GmbH, SonoScape Medical Corp., EndoChoice Holdings Inc., Micro-Tech Endoscopy Inc., CapsoVision Inc., Medrobotics Corporation, EndoMed Systems GmbH, Motus GI Holdings Inc., Endogene Ltd.

North America was the largest region in the gastrointestinal endoscopy market in 2025. The regions covered in the gastrointestinal endoscopy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the gastrointestinal endoscopy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the gastrointestinal endoscopy market by increasing costs of imported endoscopes, imaging systems, and surgical accessories. Hospitals and ambulatory surgical centers are most affected due to dependence on imported equipment. These tariffs increase procedure costs by raising capital investment and maintenance expenses for endoscopic systems. However, they encourage local manufacturing of endoscopic devices, supporting domestic production and long-term cost stabilization.

The gastrointestinal endoscopy market research report is one of a series of new reports that provides gastrointestinal endoscopy market statistics, including gastrointestinal endoscopy industry global market size, regional shares, competitors with a gastrointestinal endoscopy market share, detailed gastrointestinal endoscopy market segments, market trends and opportunities, and any further data you may need to thrive in the gastrointestinal endoscopy industry. This gastrointestinal endoscopy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Gastrointestinal endoscopy is a diagnostic and therapeutic technique that enables physicians to inspect the digestive system by inserting a long, flexible, lighted instrument called an endoscope either through the rectum or via the throat. It is employed to examine the interior of the gastrointestinal (GI) tract to identify abnormalities and diagnose various conditions.

The primary types of gastrointestinal endoscopy products include endoscopes, camera heads, visualization systems, biopsy devices, capsule endoscopes, transmitters and receivers, and robot-assisted endoscopes. Endoscopes are medical tools designed for visualizing and examining the interior of the human body or other areas that are otherwise difficult to access. The applications include OGIB (obscure GI tract bleeding), Crohn’s disease, small intestine tumors, and others, and they are used in hospitals, ambulatory surgery centers, clinics, and other healthcare settings.

The gastrointestinal endoscopy market consists of revenues earned by entities by providing colonoscopy, capsule endoscopy, and flexible sigmoidoscopy. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastrointestinal endoscopy market also includes the sales of ultrasound endoscopes, balloon dilators, gastrointestinal stents, biopsy devices, retrieval devices, ERCP devices, hemostasis devices, capsule endoscopes, gastrointestinal video scopes, and visualization systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.